argenx
Heleen Dewitte is a Senior Scientist in Discovery at argenx since December 2020, previously serving as a Scientist in the same department. Prior experience includes a Post-doctoral fellowship at Ghent University from October 2010 to December 2020, focusing on immunotherapy approaches for treating solid and haematological cancers through mRNA-nanovaccines, as well as a PhD project researching mRNA-loaded microbubbles for ultrasound-triggered dendritic cell transfection. Heleen holds dual Ph.D. degrees in Pharmaceutical Sciences from Ghent University and Medical Sciences from Vrije Universiteit Brussel, along with a Master’s in Drug Development from Ghent University. Additional experience includes various roles in pharmacy, including an internship and summer positions.
This person is not in any teams